BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2014 5:02:00 PM | Browse: 859 | Download: 881
Publication Name World Journal of Gastroenterology
Manuscript ID 5900
Country/Territory United States
Received
2013-10-11 08:44
Peer-Review Started
2013-10-15 08:31
To Make the First Decision
2013-10-29 12:32
Return for Revision
2013-10-30 10:09
Revised
2013-11-15 10:39
Second Decision
2013-12-13 14:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-13 14:57
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-02-12 12:02
Publish the Manuscript Online
2014-03-12 11:24
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Immunotherapy in gastric cancer
Manuscript Source Invited Manuscript
All Author List Satoko Matsueda and David Y Graham
Funding Agency and Grant Number
Funding Agency Grant Number
Research Center for Innovative Cancer Therapy, Cancer Vaccine Development Division, Kurume University to Matsueda S
Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (in part) DK067366 (to Graham DY)
Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (in part) DK56338 (to Graham DY)
Corresponding Author David Y Graham, MD, Michael E DeBakey VA Medical Center, Baylor College of Medicine, 2002 Holcombe Blvd, Rm 3A-318B (111D), Houston, TX 77030, United States. dgraham@bcm.edu
Key Words Gastric cancer; Immune checkpoint; Immune escape; Adoptive cell therapy; Cancer vaccine; Antibody therapy; Predictive biomarker
Core Tip In the majority of cases gastric cancer is advanced at diagnosis and although medical and surgical treatments have improved, survival rates remain poor. Cancer immunotherapy has emerged as a powerful tool for cancer therapy and has recently shown major success in breast cancer, prostate cancer and melanoma. The field of cancer immunotherapy is in the midst of a huge transition due to the discovery of immunological networks and better understanding of the molecular mechanisms of immunosuppression in the cancer microenvironment. We discuss how immunotherapy will most likely play a major role in the cure of cancer.
Publish Date 2014-03-12 11:24
Citation Matsueda S, Graham DY. Immunotherapy in gastric cancer. World J Gastroenterol 2014; 20(7): 1657-1666
URL http://www.wjgnet.com/1007-9327/full/v20/i7/1657.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i7.1657
Full Article (PDF) WJG-20-1657.pdf
Full Article (Word) WJG-20-1657.doc
Manuscript File 5900-Review.doc
Answering Reviewers 5900-Answering reviewers.pdf
Copyright License Agreement 5900-Copyright assignment.pdf
Peer-review Report 5900-Peer reviews.pdf
Scientific Editor Work List 5900-Scientific editor work list.doc